"Advanced Vision Surgery Center is the leading and most advanced surgery center in Colorado dedicated exclusively to the care of eyes."

During the past decade, Advanced Vision Research Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Advanced Vision Research Institute" are "Diabetic Macular Edema (DME)" (1 trials) and "Neovascular Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Advanced Vision Research Institute" in a lesser frequency.

Most popular intervention types in "Advanced Vision Research Institute" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "EYLEA® (aflibercept) Injection 2 mg (0.05mL)" (1 trials), "Sham" (1 trials), "UBX1325" (1 trials) and "UBX1325 injection 50 μL" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Vision Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Vision Research Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Advanced Vision Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Vision Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".